That is not oversight but the expected action because MACs typically make a determination on a claim-by-claim basis for temporary codes
You may have a little more bleeding, but this is completely OK
By staying engaged and informed, you can confidently navigate your wellness journey and continue to make choices that align with your goals
Patients who were dragging through afternoons often describe the shift as "the static turning off." Sharper mental focus and clarity B12 supports the myelin sheath that insulates your nerves, including the ones in your brain
It is believed to stimulate and elongate telomeres in human somatic cells, helping them maintain proper length
In its lawsuit, the OFA said that the FDAs decision to end the shortage was a reckless and arbitrary move and could deprive patients of a vital treatment for type 2 diabetes and obesity. In an interview with BioSpace last month, David Rosen, partner at Foley & Lardner, said that the lawsuit is a precedent in this area. Prior to the OFA suit, no one has ever challenged the FDAs decision to remove a therapy from the drug shortage list. The OFA case is still ongoing, with the next court update due on Thursday